Recent Finacing
Recent Raise
AusperBio is a clinical-stage biopharmaceutical company developing targeted antisense oligonucleotide therapies, led by AHB-137, to achieve a functional cure for chronic hepatitis B.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at AusperBio.
